Table 1 Summary of the MirSNPs studied
From: MicroRNA sequence polymorphisms and the risk of different types of cancer
| Â | Author | Year | Race | Cancer type | Method | Case/control | Polymorphism site | cancer risk |
|---|---|---|---|---|---|---|---|---|
1 | Jazdzewski K | 2008 | Caucasian | Papillary thyroid carcinoma | Northern blot analysis | 608/901 | rs2910164 | yes |
2 | Tian T | 2009 | Asian | Lung cancer | PCR-RFLP | 1058/1035 | rs11614913 | yes |
3 | Hu Z | 2009 | Asian | Breast cancer | PCR-RFLP | 1009/1093 | rs2910164,rs2292832,rs11614913,rs3746444 | rs11614913,rs3746444 yes, others no risk |
4 | Li XD | 2010 | Asian | Hepatocellular carcinoma | PCR-RFLP | 310/222 | rs11614913 | yes |
5 | Kim MJ | 2010 | Asian | Lung cancer | Melting-curve analysis | 644/644 | rs11614913 | yes |
6 | Okubo M | 2010 | Asian | Gastric cancer | PCR-RFLP | 552/697 | rs2910164,rs11614913,rs3746444 | yes |
7 | Liu Z | 2010 | Caucasian | Squamous cell carcinoma of the head and neck | PCR-RFLP | 1109/1131 | rs2910164,rs2292832,rs11614913,rs3746444 | rs3746444 yes, others no risk |
8 | Catucci I | 2010 | Caucasian | Breast cancer | Taqman | 1897/2760 | rs2910164,rs11614913,rs3746444 | rs11614913,rs3746444 yes, others no risk |
9 | Zeng Y | 2010 | Asian | Gastric cancer | PCR-RFLP | 304/304 | rs2910164 | yes |
10 | Yang R | 2010 | Caucasian | Breast cancer | Taqman | 1217/1422 | rs895819 | yes |
11 | Sun Q | 2010 | Asian | Gastric cancer | PCR-RFLP | 304/304 | rs895819 | yes |
12 | Zhan JF | 2011 | Asian | Colorectal cancer | PCR-RFLP | 252/543 | rs11614913 | yes |
13 | Farazi TA | 2011 | Asian | Breast tumors | Small RNA sequencing | 168/11 | rs6505162 | no risk |
14 | Zhou B | 2011 | Asian | Cervical squamous cell carcinoma | PCR-RFLP | 226/309 | rs2910164,rs11614913,rs3746444 | rs2910164,rs3746444 yes,others no |
15 | Akkiz H | 2011 | Mix | Hepatocellular carcinoma | PCR-RFLP | 222/222 | rs3746444 | no risk |
16 | Vinci S | 2011 | Caucasian | Lung cancer | Melting-curve analysis | 101/101 | rs2910164,rs2292832,rs11614913,rs3746444 | rs291064, rs11614913 yes,others no risk |
17 | Xiang Y | 2012 | Asian | Primary hepatocellular carcinoma | PCR-RFLP | 100/100 | rs2910164,rs3746444 | yes |
18 | Chen H | 2012 | Asian | Colorectal cancer | PCR-LDR | 126/407 | rs11614913 | no risk |
19 | Smith RA | 2012 | Caucasian | Breast cancer | Melting-curve analysis | 193/193 | rs6505162 | yes |
20 | Zhou J | 2012 | Asian | Primary liver cancer | PCR-RFLP | 186/483 | rs2910164,rs3746444 | no risk |
21 | Mittal RD | 2011 | Asian | Bladder cancer | PCR-RFLP | 212/250 | rs2910164,rs11614913,rs3746444 | no risk |
22 | Ryan BM | 2012 | Mix | Colorectal cancer | Taqman | 245/466 | rs4919510 | no risk |
23 | Huang AJ | 2012 | Asian | Breast tumors | SNPlex assay | 1432/1934 | rs4919510 | yes |
24 | Shi D | 2012 | Asian | Renal cell cancer | Taqman | 594/600 | rs895819 | yes |
25 | Hezova R | 2012 | Caucasian | Colorectal cancer | TaqMan | 192/212 | rs11614913,rs895819,rs2910164 | no risk |
26 | Zhou Y | 2012 | Asian | Gastric cancer | Locus specific single-base extension reactions | 311/425 | rs895819,rs6505162,rs2910164,rs7372209,rs531564 | rs895819 yes, others no risk |
27 | Zhang M | 2012 | Asian | Breast cancer | PCR-RFLP | 252/248 | rs2043556,rs2292832,rs895819,rs11614913,rs2682818 | no risk |
28 | Zhang MW | 2012 | Asian | Gastrointestinal cancer | PCR-RFLP | 762/757 | rs2043556,rs2292832 | no risk |
29 | Wei WJ | 2013 | Asian | Thyroid carcinoma | iPLEX GOLD | 753/1244 | rs2910164 | no risk |
30 | Ma L | 2013 | Asian | Colorectal cancer | TaqMan | 1147/1203 | rs2910164 | yes |
31 | Orsós Z | 2013 | Caucasian | Head and neck cancer | PCR-CTPP | 468/468 | rs2910164 | yes |
32 | Yamashita J | 2013 | Asian | Malignant melanoma | PCR-RFLP | 50/107 | rs2910164 | yes |
